Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023

SELL
$68.48 - $81.09 $122,236 - $144,745
-1,785 Reduced 37.85%
2,931 $210,000
Q3 2022

Nov 09, 2022

SELL
$0.13 - $76.84 $180 - $106,500
-1,386 Reduced 22.71%
4,716 $335,000
Q1 2022

May 13, 2022

BUY
$61.48 - $73.72 $375,150 - $449,839
6,102 New
6,102 $466,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $126B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Mma Asset Management LLC Portfolio

Follow Mma Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mma Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mma Asset Management LLC with notifications on news.